Observational Study
Copyright ©The Author(s) 2025.
World J Transplant. Jun 18, 2025; 15(2): 102003
Published online Jun 18, 2025. doi: 10.5500/wjt.v15.i2.102003
Table 2 Clinical characteristics of the patients, n (%)
Characteristics
CP (n = 77)
LT (n = 65)
Etiology of cirrhosis
Alcoholic42 (54.5)33 (50.8)
Nonalcoholic fatty liver disease23 (29.9)10 (15.4)
Hepatitis C virus13 (16.9)21 (32.3)
Hepatocellular carcinoma12 (15.6)16 (24.6)
Other15 (19.5)26 (40)
Model for end-stage liver disease score
6 to 1017 (22.1)NA
11 to 1427 (35.1)NA
15 to 2018 (23.4)NA
≥ 213 (3.9)NA
Not available12 (15.6)NA
Child-turcotte-Pugh classification
A27 (35.1)NA
B32 (41.6)NA
C6 (7.8)NA
Not available12 (15.6)NA
Decompensations/complications
07 (9.1)27 (41.5)
1 to 235 (45.5)32 (49.2)
≥ 335 (45.5)6 (9.2)
Number of hospitalizations
019 (24.7)21 (32.3)
114 (18.2)16 (24.6)
2 to 427 (35.1)16 (24.6)
≥ 517 (22.1)12 (18.5)